Silencing a Killer Among Us: Ethanol Impairs Immune Surveillance of Activated Stellate Cells by Natural Killer Cells

Gastroenterology

Volumn 134, Issue 1, 2008, Pages 351-353

  Arteel, Gavin E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; APOPTOSIS; CELL ACTIVITY; DISEASE COURSE; EDITORIAL; FIBROSIS; GENETIC RISK; HEPATITIS C VIRUS; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LIVER CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; STELLATE CELL;

EID: 37349064430     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.11.061     Document Type: Editorial

References (25)

1. Diehl A.M. Liver disease in alcohol abusers: clinical perspective. Alcohol 27 (2002) 7-11
2. Lelbach W.K. Liver damage in chronic alcoholism: results of a clinical, clinical-chemical and bioptic-histological study in 526 alcoholic patients during a low calorie diet in an open drinking sanatorium. Acta Hepatosplenol 13 (1966) 321-349
3. Mann R.E., Smart R.G., and Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 27 (2003) 209-219
4. Mandayam S., Jamal M.M., and Morgan T.R. Epidemiology of alcoholic liver disease. Semin Liver Dis 24 (2004) 217-232
5. Day C.P. Who gets alcoholic liver disease: nature or nurture?. J R Coll Physicians Lond 34 (2000) 557-562
6. Peters M.G., and Terrault N.A. Alcohol use and hepatitis C. Hepatology 36 (2002) S220-S225
7. Uchimura Y., Sata M., Kage M., et al. A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 15 (1995) 300-306
8. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349 (1997) 825-832
9. Westin J., Lagging L.M., Spak F., et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 9 (2002) 235-241
10. Ostapowicz G., Watson K.J., Locarnini S.A., et al. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology 27 (1998) 1730-1735
11. Jeong W.-I., Park O., and Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-γ contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134 (2008) 248-258
12. Biron C.A., Nguyen K.B., Pien G.C., et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
13. Rockey D.C., and Chung J.J. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis. J Investig Med 42 (1994) 660-670
14. Inagaki Y., Nemoto T., Kushida M., et al. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 38 (2003) 890-899
15. Radaeva S., Sun R., Jaruga B., et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130 (2006) 435-452
16. Morishima C., Paschal D.M., Wang C.C., et al. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 43 (2006) 573-580
17. Hebert P., and Pruett S.B. Ethanol decreases natural killer cell activation but only minimally affects anatomical distribution after administration of polyinosinic:polycytidylic acid: role in resistance to B16F10 melanoma. Alcohol Clin Exp Res 27 (2003) 1622-1631
18. Wu W.J., and Pruett S.B. Involvement of catecholamines and glucocorticoids in ethanol-induced suppression of splenic natural killer cell activity in a mouse model for binge drinking. Alcohol Clin Exp Res 21 (1997) 1030-1036
19. Collier S.D., Wu W.J., and Pruett S.B. Ethanol suppresses NK cell activation by polyinosinic-polycytidylic acid (poly I:C) in female B6C3F1 mice: role of endogenous corticosterone. Alcohol Clin Exp Res 24 (2000) 291-299
20. Jirova D., Sperlingova I., Halaskova M., et al. Immunotoxic effects of carbon tetrachloride-the effect on morphology and function of the immune system in mice. Cent Eur J Public Health 4 (1996) 16-20
21. Li Z., and Diehl A.M. Innate immunity in the liver. Curr Opin Gastroenterol 19 (2003) 565-571
22. Nakajima T., Mizushima N., and Kanai K. Relationship between natural killer activity and development of hepatocellular carcinoma in patients with cirrhosis of the liver. Jpn J Clin Oncol 17 (1987) 327-332
23. Diefenbach A., and Raulet D.H. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev 188 (2002) 9-21
24. Kaplan D.H., Shankaran V., Dighe A.S., et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 95 (1998) 7556-7561
25. Smyth M.J., Thia K.Y., Street S.E., et al. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192 (2000) 755-760